PubMed Health⌕ Search

PubMed · 8379994

Validity of case-finding tools in a national tuberculosis programme.

Abstract

For case-finding under the District Tuberculosis Programme (DTP) in India, the recommended method is sputum smear microscopy of chest symptomatics attending the health institutions on their own. It is universally followed, with a slight variation in the procedure of initial screening of outpatient attendance respectively at the District Tuberculosis Centre (DTC) and at peripheral health institutions (PHI). However it may be argued that smear microscopy of all patients with chest symptoms results in a high workload in terms of positivity rate for examinations done as well as for its comparatively lower predictive value of negativity. It would be interesting in this context to estimate validity of screening and diagnosis obtained under operational conditions. The data available from some of the field surveys and from the DTP situation have been analysed for the above purpose. Examined in the context of statistical reliability of tests, the methodology of prior X-ray screening adopted by the DTC for case-finding for tuberculosis appears to be well founded. In contrast to the DTC, the need for X-ray screening at PHIs does not arise, as the procedure of patients being subjected to screening for the presence of chest symptoms has in itself a very high specificity of about 97%. The results show that X-ray and smear microscopy should not be used indiscriminately as case-finding tools in mass case-finding programmes, as their predictive values of positivity are likely to be very low at the current case prevalence rates in the community, being 2-8 per thousand.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

V H Balasangameshwara, A K Chakraborty. 1993. Validity of case-finding tools in a national tuberculosis programme.. https://doi.org/10.1016/0962-8479(93)90069-a

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗